
55.58 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 46.41 Today|||52-Week Range 72.11 | +0.82% Year-to-Date |
Are Medical Stocks Lagging Galapagos (GLPG) This Year? 9:40am / Zacks.com - Paid Partner Content | Acadia (ACAD) Up on FDA Briefing Document for Nuplazid sNDA Jun 16 / Zacks.com - Paid Partner Content |
Previous close | 55.95 |
Today’s open | 55.27 |
Day’s range | 55.01 - 55.90 |
Volume | 6,830 |
Average volume (3 months) | 298,648 |
Market cap | $3.7B |
Earnings growth (last year) | +57.70% |
Earnings growth (this year) | +7.26% |
Earnings growth (next 5 years) | -12.57% |
Revenue growth (last year) | +5.16% |
P/E ratio | NM |
Price/Sales | 6.30 |
Price/Book | 1.22 |
Today’s change | Today’s % change | |
---|---|---|
TPTXTurning Point Therap... | +0.21 | +0.28% |
KRTXKaruna Therapeutics ... | +4.12 | +3.41% |
MRTXMirati Therapeutics ... | -1.26 | -1.84% |
---- |
Next reporting date | August 4, 2022 |
EPS forecast (this quarter) | -$0.74 |
Annual revenue (last year) | $573.1M |
Annual profit (last year) | -$148.2M |
Net profit margin | -25.87% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Mechelen, Brussels Region |